Folic acid is not recommended because of the potentially low activity of dihydrofolate reductase in cerebral folate deficiency, and because of its tight binding to folate receptor alpha that results in reduced cerebral transport of 5-methyltetrahydrofolate. This evidence concerns the gene DHFR and folate deficiency.